Well superstar...I'd love to go head to head with you (not), but unfortunately (or fortunately, lol) I have better things to do then trade, post and bash on message boards all day and all night long.
Try this though, take a look at all the biotechs without a product -- I'll even let you omit those currently in phase III testing -- and see how many have market caps over 175 mill., and tell me how many you find. Granted, it won't be a majority, but I think you'll find a few. I'll give you a head start: look at PRAN.
Ps. I may be a sucker on this one, that remains to be seen, but in a liquid market with a modest position ( and break even, currently) , I can deal with that.
